Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1991
12/25/1991CN1057262A Cyclic amide derivatives
12/25/1991CN1057260A Anti-viral compounds
12/25/1991CN1057259A Piperidyloxy-and quinuclidinyloxy-isoxazole derivatives, their preparation and their therapeutic use
12/25/1991CN1057257A Imidazole derivatives, their preparation process, intermediates obtained, their use as medicaments and pharmaceutical compositions containing them
12/25/1991CN1057194A Prodn. and use of porphyrins
12/25/1991CN1057193A Method of dispensing solution for haemorrhoids
12/25/1991CN1057164A Method for mfg .bubble chewing gum for preventing dental caries
12/25/1991CN1015175B Anticonvulsant agents
12/25/1991CA2084288A1 Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands
12/25/1991CA2043525A1 Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method
12/24/1991US5075499 Calcium supplementation by dicalcium citrate-lactate
12/24/1991US5075454 Chemical intermediate, antitumor agent
12/24/1991US5075445 Viricides
12/24/1991US5075440 Hypotensive, bronchodilator agents
12/24/1991US5075341 Treatment for cocaine abuse
12/24/1991US5075340 Acne, dermatitis, aging
12/24/1991US5075339 Antiinflammatory agents, antiallergens
12/24/1991US5075338 Method of treatment of learning deficiency
12/24/1991US5075337 Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
12/24/1991US5075335 Enzyme inhibitors
12/24/1991US5075334 Excretion of potassium ion by prostanoic acid derivatives
12/24/1991US5075333 Tetrahydronaphthalene and indane compounds useful for reversing the photo-damage in sun-exposed skin
12/24/1991US5075331 For skin disorders
12/24/1991US5075329 Blocking toxic effects of oxygen free radicals
12/24/1991US5075325 N-aminobutyl-n-phenylarylamide derivatives, their preparation and their application in therapy
12/24/1991US5075324 Aralkyl-1,4-dihydropyridines, a method for their preparation and pharmaceutical composition containing them
12/24/1991US5075322 Antiallergens
12/24/1991US5075321 Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
12/24/1991US5075320 Method and composition for treating parasitic infestation of animals
12/24/1991US5075319 Pyridinyl-quinolone compounds, their preparation and use
12/24/1991US5075318 For treating psychological disorders, Parkinson's disease
12/24/1991US5075317 2,8-dimethyl-1-oxa-8-azospiro(4.5) decan-3-one; alzheimer*s di sease
12/24/1991US5075314 Prevention nighttime urination in animals
12/24/1991US5075313 For bindign to cholecystokinin receptors
12/24/1991US5075312 Prevention nighttime urination in young animals
12/24/1991US5075311 Hmg-coa reductase inhibiting substituted pryido (2,3-d) pyrimidines
12/24/1991US5075310 Pyrimidone derivatives as bronchodilators
12/24/1991US5075308 Method for treating urinary obstruction
12/24/1991US5075307 Paraherquamide and dihydroparaherquamide as antihelminthic agents
12/24/1991US5075306 Thiazoloquinoxalines
12/24/1991US5075305 Compound, composition and use
12/24/1991US5075304 Imidazoquinoxaline compounds and their preparation and use
12/24/1991US5075303 Pyridine derivatives
12/24/1991US5075302 Treating hypertension, congestive heart failure
12/24/1991US5075301 Furan derivatives useful for the treatment of gastro-intestinal disorders
12/24/1991US5075300 Novel compounds
12/24/1991US5075299 Cephalosporin compounds and antibacterial agents
12/24/1991US5075298 Cephalosporins
12/24/1991US5075295 Novel oxytetracycline compositions
12/24/1991US5075290 Use of adenosine, adenosine analogs or nucleoside uptake blockers, e.g. dipyridamole, as drug treatments for obstructive sleep apnea and snoring
12/24/1991US5075289 Improved activity and therapeutic ratios
12/24/1991US5075230 Stabilized plasminogen activator precursor and method of producing the same
12/24/1991US5075116 Composition and method for treatment of macular degeneration
12/24/1991US5075113 Products comprising an emulsion of water and oily paraffinic hydrocarbons with added extracts of lecithin and processes for production
12/24/1991US5075109 Administering in encapsulated form
12/24/1991US5075105 Composition for treatment of progressive myopia
12/24/1991US5075104 Carbopol
12/24/1991CA1293517C Agent and process for the oxidative dyeing of hair with 3-(2',2',2'-trifluoro-ethyl) aminophenol derivatives and novel 3-(2',2',2'-trifluoro-ethyl) aminophenol derivatives
12/24/1991CA1293514C Isoxazolylethanol derivatives
12/24/1991CA1293511C Allenyl amines
12/24/1991CA1293508C Dihydropyridinelactols, processes for their preparation and their use as medicaments
12/24/1991CA1293504C Therapeutic use of tin mesoporphyrin
12/24/1991CA1293502C Pyridine compounds
12/24/1991CA1293449C Controlled release drug preparation
12/24/1991CA1293447C Use of 3'-deoxythymidin-2'-ene (3'-deoxy-2', 3'- didehydrothymidine)in treating patients infected with retroviruses
12/24/1991CA1293446C Therapeutic agents in the form of submicroscopic particles against leishmaniasis and pharmaceutical compositions containing them
12/24/1991CA1293445C Cephalosporin injection
12/24/1991CA1293444C Amino acid chelated compositions for delivery to specific biologicaltissue sites
12/23/1991WO1992000298A1 Heterocyclic compounds and their preparation and use
12/23/1991WO1992000293A1 Bis-benzo or benzopyrido cyclo hepta piperidene, piperidylidene and piperazine compounds and compositions
12/23/1991WO1992000285A1 Tetrazole derivative and medicine
12/23/1991WO1992000276A2 Angiotensis converting enzyme inhibitors
12/23/1991WO1992000102A1 Novel treatment
12/23/1991WO1992000070A1 Piperidyl-substituted indoles
12/23/1991CA2086117A1 Tetrazole derivatives and drugs
12/23/1991CA2085993A1 Angiotensin converting enzyme inhibitors
12/23/1991CA2085873A1 Treatment
12/23/1991CA2085591A1 Heterocyclic compounds and their preparation and use
12/23/1991CA2045257A1 Acyl benzoxazolinones, their preparation process and the pharmaceutical compositions containing them
12/23/1991CA2045256A1 Chalcone, their preparation process and the pharmaceutical compositions containing them
12/22/1991WO1991019717A1 Polycyclic guanine derivatives
12/22/1991CA2045279A1 Use of particular compounds for manufacture of pharmaceutical formulations for treatment against various parasites, mycoplasmas, other indications and other infections
12/22/1991CA2045095A1 Heterocyclene derivatives
12/22/1991CA2045048A1 9-amino-2-phenylbicyclo[3.3.1] nonanes and 9-amino-2-phenylbicyclo [3.3.1] non-2-enes and drugs containing them
12/22/1991CA2044219A1 Bicyclic heterocyclic compounds
12/21/1991WO1991019729A1 Nucleic acid probes and protein probes
12/21/1991WO1991019711A1 Substituted benzimidazoles, process for their preparation and their pharmaceutical use
12/21/1991WO1991019707A2 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
12/21/1991WO1991019474A1 Transdermal administration of buprenorphine
12/21/1991CA2085126A1 Transdermal administration of buprenorphine
12/21/1991CA2083714A1 Substituted benzimidazoles, process for their preparation and their pharmaceutical use
12/21/1991CA2081577A1 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1, 3-benzoxazine-4-ones
12/21/1991CA2059559A1 Nucleic acid probes and protein probes
12/21/1991CA2058920A1 17.beta.-n-monosubstituted adamantyl/carbamoyl-4-aza-5.alpha.-androst-1-en-3-ones and androstan-3-ones as 5.alpha.-reductase
12/21/1991CA2044977A1 Pharmaceutical combination preparations containing cephalosporin and xanthine derivatives and their use
12/21/1991CA2044922A1 17.beta.-hydroxybenzoyl-4-aza-5.alpha.-androst-1-en-3-ones as testoste rone reductase inhibitors
12/21/1991CA2044921A1 Specific 17 .beta.-thiobenzoyl-4-aza-5 .alpha.-androst-1-en-3-ones as antiandrogenic agents
12/21/1991CA2044914A1 17.beta.-aminobenzoyl-4-5 .alpha.-androst-1-en-3-ones as benign prostatic hypertrophy agents
12/21/1991CA2044906A1 Beta-lactams as antihypercholesterolemics
12/21/1991CA2044905A1 Selected 17 .beta.-polyaroyl-4-aza-5 .alpha.-androst-1-en-3-ones as steroidal reductase inhibitors
1 ... 7305 7306 7307 7308 7309 7310 7311 7312 7313 7314 7315 7316 7317 7318 7319 7320 7321 7322 7323 7324 7325 ... 7860